Skip to content
Archive

Tag: AnnJi Pharmaceutical Co.

Health

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

TAIPEI, Oct. 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food &…

Health

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease

TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food &…